Which has the lower trailing P/E, BIO or CHE?

CHE has the lower trailing P/E: BIO trades at 46.99 and CHE at 26.26. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or CHE?

Over the past five years, CHE grew revenue faster — BIO at a 0.29% CAGR versus CHE at 4.12%.

Does BIO or CHE pay a bigger dividend?

CHE pays a dividend (0.48% yield), while BIO has no payments in the available dividend history.

Is BIO or CHE more profitable?

CHE runs the higher net margin — BIO at 8.59% versus CHE at 10.60%.

How have BIO and CHE total returns compared?

Over the past 10 years, BIO delivered 9.86% and CHE delivered 15.21% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Chemed Corporation (CHE)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Chemed Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 29, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$10.44B

$387.70HealthcareAt close: Aug 28, 2026, 4:00 PM ET

CHE

Chemed Corporation

$6.84B

$523.38HealthcareDelayed quote: Aug 28, 2026, 4:00 PM EDT

Total return — BIO vs CHE

growth of $100 · dividends reinvested · last 10y

BIO +143.3% (+9.3%/yr)CHE +291.9% (+14.6%/yr)CHE compounded faster over this window

BIO CHE

BIO vs CHE: by the numbers

•BIO is the larger company ($10.44B vs $6.84B market cap).
•CHE trades at the lower trailing earnings multiple (26.26 vs 46.99 P/E), one valuation lens rather than an overall verdict.
•CHE converts more revenue to profit (10.60% vs 8.59% net margin).
•CHE grew revenue faster over the past five years (4.12% vs 0.29% CAGR).
•CHE pays a dividend (0.48% yield), while BIO has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BIO	CHE
P/E ratio	46.99	26.26
Forward P/E	40.21	20.49
P/S ratio	4.01	2.71
P/B ratio	1.45	8.45
EV / EBITDA	28.97	17.59
FCF yield	3.40%	4.61%

Profitability

Metric	BIO	CHE
Gross margin	51.90%	30.44%
Operating margin	9.08%	13.46%
Net margin	8.59%	10.60%
ROE	3.10%	33.11%
ROIC	1.54%	19.48%

Dividends

Metric	BIO	CHE
Dividend yield	N/A	0.48%
Payout ratio	N/A	13.57%

Growth (annualized)

Metric	BIO	CHE
Revenue CAGR (5Y)	0.29%	4.12%
EPS CAGR (5Y)	-26.27%	-1.65%
FCF CAGR (5Y)	-9.65%	-5.44%
Total return CAGR (5Y)	-13.32%	2.38%

Frequently asked

Which has the lower trailing P/E, BIO or CHE?: CHE has the lower trailing P/E: BIO trades at 46.99 and CHE at 26.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or CHE?: Over the past five years, CHE grew revenue faster — BIO at a 0.29% CAGR versus CHE at 4.12%.
Does BIO or CHE pay a bigger dividend?: CHE pays a dividend (0.48% yield), while BIO has no payments in the available dividend history.
Is BIO or CHE more profitable?: CHE runs the higher net margin — BIO at 8.59% versus CHE at 10.60%.
How have BIO and CHE total returns compared?: Over the past 10 years, BIO delivered 9.86% and CHE delivered 15.21% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full CHE analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Chemed P/E ratio Chemed dividend yield Bio-Rad Laboratories ROE Chemed ROE Bio-Rad Laboratories operating margin Chemed operating margin Bio-Rad Laboratories revenue growth Chemed revenue growth Bio-Rad Laboratories free cash flow Chemed free cash flow

Bio-Rad Laboratories & Chemed appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 29, 2026.